Timing of renal-replacement therapy in patients with acute kidney injury and sepsis.
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acute kidney injury is the most frequent complication in patients with septic shock and is an independent risk factor for death. Although renal-replacement therapy is the standard of care for severe acute kidney injury, the ideal time for initiation remains controversial. METHODS: In a multicenter, randomized, controlled trial, we assigned patients with early-stage septic shock who had severe acute kidney injury at the failure stage of the risk, injury, failure, loss, and end-stage kidney disease (RIFLE) classification system but without life-threatening complications related to acute kidney injury to receive renal-replacement therapy either within 12 hours after documentation of failure-stage acute kidney injury (early strategy) or after a delay of 48 hours if renal recovery had not occurred (delayed strategy). The failure stage of the RIFLE classification system is characterized by a serum creatinine level 3 times the baseline level (or ≥4 mg per deciliter with a rapid increase of ≥0.5 mg per deciliter), urine output less than 0.3 ml per kilogram of body weight per hour for 24 hours or longer, or anuria for at least 12 hours. The primary outcome was death at 90 days. RESULTS: The trial was stopped early for futility after the second planned interim analysis. A total of 488 patients underwent randomization; there were no significant between-group differences in the characteristics at baseline. Among the 477 patients for whom follow-up data at 90 days were available, 58% of the patients in the early-strategy group (138 of 239 patients) and 54% in the delayed-strategy group (128 of 238 patients) had died (P=0.38). In the delayed-strategy group, 38% (93 patients) did not receive renal-replacement therapy. Criteria for emergency renal-replacement therapy were met in 17% of the patients in the delayed-strategy group (41 patients). CONCLUSIONS: Among patients with septic shock who had severe acute kidney injury, there was no significant difference in overall mortality at 90 days between patients who were assigned to an early strategy for the initiation of renal-replacement therapy and those who were assigned to a delayed strategy. (Funded by the French Ministry of Health; IDEAL-ICU ClinicalTrials.gov number, NCT01682590 .).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These three RCTS compared a strategy of low tidal volume and limited plateau pressure with a strategy using higher tidal volume and plateau pressure; pooled data suggest reduced mortality (RR, 0.83; 95% CI, 0.70 to 0.97) and more ventilator-free days (MD 1.8 days; 95% CI, 0.35 to 3.25) in patients managed with low plateau pressures.”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [426]
In the citing paper
“It was stopped early, after the second planned interim analysis, for futility.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [507]
In the citing paper
“The IDEAL-ICU trial [507] did not report central venous access device (CVAD) infections: the results for this outcome are unchanged from 2016.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [507]
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.1 · Cited by 4,326
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Hoste, E. A. J., Bagshaw, S. M., Bellomo, R., Cely, C. M., Colman, R., Cruz, D. N., Edipidis, K., Forni, L. G., Gomersall, C. D., Govil, D., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3934-7 · Cited by 3,061 · cited 1×
“Ventricular tachycardia or ventricular fibrillation 10 (4) 3 (1) 0.”
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902413 · Cited by 1,473
Initiation strategies for renal-replacement therapy in the intensive care unit.
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603017 · Cited by 1,243 · cited 1×
“Neurologic complication 29 (12) 20 (8) 0.”
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., Susantitaphong, P., Rocco, M., Vanholder, R., Sever, M. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60126-x · Cited by 1,154
Research works printed but not linked: 1
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138.
Cited by
Items 301–400 of 792
Fu, Z., Hao, X., Lv, Y., Hong, Q., Feng, Z., & Liu, C. (2024) · BMC Medicine · doi:10.1186/s12916-024-03639-x · Cited by 10
“However, it should also be attention that although dialysis is regarded as the standard therapeutic option for severe AKI, the ideal timing of initiation of dialysis remains controversial [28, 29].”
BackgroundBiomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO study
Chaïbi, K., Picod, A., Boubaya, M., Tubiana, S., Jullien, V., Magréault, S., Placier, S., Mallet, J., Louis, G., Martin‐Lefèvre, L., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05439-y · Cited by 9
“One of the principal strengths of our study lies in its methodological rigor, informed by the latest evidence from randomized controlled trials on RRT timing [7, 8] [6, 9].”
Self-citationChanging the terminology from kidney replacement therapy to kidney support therapy
Raina, R., Joshi, H., & Chakraborty, R. (2020) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13584 · Cited by 8
“Similarly, the Initiation of Dialysis Early vs Delayed in the intensive care unit (IDEAL-ICU) trial reported no significant difference in 90-day mortality in the early vs late groups (58% vs 54%, respectively) and the authors concluded that mortality rates were not affected by the timing of KRT initiation.(11) Therefo…”
BackgroundLin, J., Zhuang, H. Z., Zhi, D., Qi, Z., Bai, J., Dong, L., Liu, S., & Duan, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.762112 · Cited by 7
Ethgen, O., Zarbock, A., Koyner, J. L., Echeverri, J. E., Harenski, K., Priyanka, P., & Kellum, J. A. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.12.011 · Cited by 8
Continuous Renal Replacement Therapy in Critically Ill Children
Demirkol, D. (2022) · Turkish Archives of Pediatrics · doi:10.5152/turkarchpediatr.2022.22082 · Cited by 7
Park, H., Yang, J., & Chun, B. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286246 · Cited by 7
“Additionally, to improve the quality of CRRT, such as the optimal start time of CRRT [25, 26], severity scores are used for providing the objectivity and reliability of the study with population stratification and balanced randomization to ensure that disease severity does not affect the statistical outcome [27].”
MethodLeitliniengerechte Therapie der Sepsis
Schmoch, T., Weigand, M. A., & Brenner, T. (2023) · Die Anaesthesiologie · doi:10.1007/s00101-023-01354-5 · Cited by 8
Cuartero, M., Betbese, A. J., Nunez, K. E., Baldirà, J., & Ordóñez‐Llanos, J. (2019) · Disease Markers · doi:10.1155/2019/8480925 · Cited by 7
“Despite NGAL’s promising results in general ICU population, the AKIKI [34], ELAIN [35], and the most recent IDEAL-ICU [36] trials showed that wbNGAL combined with KDIGO staging did not improve the timing of renal replacement therapies or patient’s prognosis.”
ResultRenal replacement therapy during extracorporeal membrane oxygenation
Subbarayan, B., Vivek, V., & Kuppuswamy, M. K. (2020) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-019-00920-0 · Cited by 7
Regenerative Role of Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury
Medica, D., Dellepiane, S., & Cantaluppi, V. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000511347 · Cited by 7
Kelly, Y. P., Mistry, K., Ahmed, S., Shaykevich, S., Desai, S. P., Lipsitz, S. R., Leaf, D. E., Mandel, E. I., Robinson, E., McMahon, G. M., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02060221 · Cited by 7
The Current State of Renal Replacement Therapy in the Treatment of Sepsis
Kim, T. G., Магомедов, М. А., Николаевич, П. Д., Владимирович, З. М., Marukhov, A. V., & Чубченко, Н. В. (2021) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2021-18-4-80-89 · Cited by 7
Popoff, B., Cabon, S., Cuggia, M., Bouzillé, G., & Clavier, T. (2025) · JMIR Medical Informatics · doi:10.2196/63709 · Cited by 6
“While significant research has focused on the optimal timing for initiating CRRT [11,12], much less attention has been given to the question of when and how to discontinue this therapy [13].”
Guo, L., Wu, X., Cui, X., Li, M., Yang, L., Feng, Y., Zhan, Q., & Huang, L. (2024) · Kidney Diseases · doi:10.1159/000539139 · Cited by 6
“2, revealed no statistical differences in the rates of mortality and irreversible AKI [11 – 13].”
BackgroundChaïbi, K., Dreyfuss, D., & Gaudry, S. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08254-9 · Cited by 6
Chaïbi, K., Akrour, Y., Louis, G., Lefevre, L. M., Pons, B., Moschietto, S., Boulet, E., Hajage, D., Lebbah, S., Quenot, J.-P., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08357-x · Cited by 6
Self-citationWang, K., Xiong, H., Zhu, Y., Zhou, Y., & Kang, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-46063-2 · Cited by 8
“These trials have fundamentally shifted global practice toward a more conservative threshold for RRT initiation 38 .”
Timing of kidney replacement therapy initiation in acute kidney injury
Meraz-Muñoz, A., Bagshaw, S. M., & Wald, R. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000707 · Cited by 6
Suffering and Symptoms At the End of Life in ICU Patients Undergoing Renal Replacement Therapy
Ramer, S. J., Viola, M., Maciejewski, P. K., Reid, M. C., & Prigerson, H. G. (2021) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091211005707 · Cited by 7
“Median length of stay in the hospital in days (IQR) was 13 (6-25); in the ICU, it was 7 (4-13).”
BackgroundUromodulin in sepsis and severe pneumonia: a two-sample Mendelian randomization study
Eriksson, M., Lipcsey, M., Ilboudo, Y., Yoshiji, S., Richards, J. B., & Hultström, M. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00145.2023 · Cited by 6
Suzuki, G., Nishioka, S., Kobori, T., Masuyama, Y., Yamamoto, S., Serizawa, H., Nakamichi, Y., & Honda, M. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2404237 · Cited by 6
CSN COVID-19 Rapid Review Program: Management of Acute Kidney Injury
Clark, E. G., Hiremath, S. S., Soroka, S., Wald, R., Weir, M. A., On behalf of the CSN COVID-19 Rapid Response Team, Antonsen, J. E., Banks, C. A., Clark, D. A., Copland, M. A., et al. (2020) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358120941679 · Cited by 7
Wang, J., Wu, Z., Wen, Q., & Wang, X. (2021) · Journal of International Medical Research · doi:10.1177/03000605211042981 · Cited by 6
RetractedPeng, W., Wu, Y., Lu, R., Yunpeng, Z., Chen, J., & Pan, P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.936927 · Cited by 5
“Recommendations were to set a blood flow rate of 150–250 ml/min, and a dialysate flow rate of 300–500 ml/min (61, 62).”
BackgroundMethodUnsupervised clustering reveals phenotypes of AKI in ICU COVID-19 patients
Sangla, F., Marchi, E., Assouline, B., Terrier, C. L., Sgardello, S. D., Pugin, J., Criton, G., & Legouis, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.980160 · Cited by 7
“Finally, mortality varied between the 3 clusters (18% [3-29], 30% [8-54] and 40% [28-52] respectively, Figure 3e).”
BackgroundRisk Classification and Subphenotyping of Acute Kidney Injury: Concepts and Methodologies
Neyra, J. A., Chen, J., Bagshaw, S. M., & Koyner, J. L. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.10.011 · Cited by 6
Chadha, R., Sakai, T., Rajakumar, A., Shingina, A., Yoon, U., Patel, D., Spiro, M. D., Bhangui, P., Sun, L.-Y., Humar, A., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004803 · Cited by 6
Zheng, M., Yin, C., Cao, Y., Zhang, Y., Zhang, K., Zhang, X., Bian, W., & Wang, L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043385 · Cited by 7
Acute Kidney Injury in ECMO Patients
Ostermann, M., & Lumlertgul, N. (2021) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-73231-8_18 · Cited by 8
Initiation of renal replacement therapy in patients with sepsis: more to it than meets the eye
Uhel, F., Sengers, H. P., & van der Poll, T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.12.36 · Cited by 7
“In a recent issue of the New England Journal of Medicine, Barbar and colleagues published the results of the IDEALICU study, focusing on the outcome of patients with a severe AKI in the context of septic shock (15).”
BackgroundFailing kidneys: renal replacement therapies in the ICU
Patel, P. P., & Egodage, T. (2024) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2024-001381 · Cited by 6
Alactic base excess predicts the use of renal replacement therapy in patients with septic shock
Díaz, J. S. S., Moguel, K. G. P., Gaxiola, F. B., Ruiz, J. M. R., Pérez‐Nieto, O. R., & Sánchez, M. V. C. (2023) · Renal Replacement Therapy · doi:10.1186/s41100-023-00494-z · Cited by 5
“Our study demonstrated that ABE ( ≤ − 5.7 mmol/L) and urea (> 75 mg/dL) are independent risk factors for RRT. Studies on the timing of RRT have included severe metabolic acidosis as one of the absolute indications; in fact, the variables considered were pH < 7.15 and HCO 3 − < 18 mEq/L [28, 29].”
BackgroundInfluentialYagi, K., Fujii, T., Kageyama, A., Takagi, T., Ikeda, J., & Uezono, S. (2024) · Blood Purification · doi:10.1159/000539810 · Cited by 5
Neto, A. S., Bellomo, R., Wald, R., Bagshaw, S. M., & on behalf of the STARRT-AKI Investigators (2025) · Blood Purification · doi:10.1159/000547141 · Cited by 7
“However, little is known about within-modality practice variation and its associations with clinical outcomes [1–9].”
Robayo-Amórtegui, H., Pérez-Garzón, M., Forero-Delgadillo, A. J., Valenzuela-Faccini, N., la Peña, M. B.-D., Poveda-Henao, C., Bastidas, A., & Díaz, M. A. M. (2025) · Perfusion · doi:10.1177/02676591251360900 · Cited by 5
The role of Heme oxygenase-1 (HO-1) in sepsis-associated organ damage: A systematic review
Li, T., Wang, D., Xu, L., Xu, Z., Li, Z., Bai, X., Zhao, H., Yang, J., Liu, Y., & Wang, Y.-C. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156175 · Cited by 6
EACTS/STS/AATS Guidelines on temporary mechanical circulatory support in adult cardiac surgery
Potapov, E. V., Whitman, G. J. R., John, R., Lanmüeller, P., Tučanová, Z., Arora, R. C., Atluri, P., de Waal, E. E. C., Faerber, G., Loforte, A., et al. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.09.046 · Cited by 6
Volume Management with Kidney Replacement Therapy in the Critically Ill Patient
Wang, C. H., Fay, K., Shashaty, M. G. S., & Negoianu, D. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000164 · Cited by 5
A retrospective analysis: the outcome of renal replacement therapies in critically ill children
Çeleğen, K., & Çeleğen, M. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220837 · Cited by 5
The intensity of organ support: Restrictive or aggressive therapy for critically ill patients
Li, H., Li, Y., Fu, Y., Zhang, X., & Zhang, D. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.04.002 · Cited by 5
“…shock patients with severe AKI who received an early RRT with a median of 7.6 h and those who had a delayed strategy with a median of 51.5 h. [ 50 ] Nutrition Support: the Early Restrictive vs. Aggressive Nutrition Support Sufficient and appropriate nutrition is essential for sustaining the…”
MethodInfluential10 tips on how to use dynamic risk assessment and alerts for AKI
Quickfall, D., La, A. M., & Koyner, J. L. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae325 · Cited by 5
Jiao, R., Lu, X., Liu, M., Zhu, J., Sun, L., & Liu, N. (2025) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2024.10.034 · Cited by 5
Dialysis Dependence in Standard versus Accelerated Initiation of KRT in AKI
McCoy, I. E., Liu, K. D., Ghamarian, E., Quenot, J., Zarbock, A., Bihorac, A., Khoo, B. Z. E., Gallagher, M., Du, B., Joannidis, M., et al. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000672 · Cited by 6
Self-citationJulien, M., Rafat, C., Raffray, L., Vacher-Coponat, H., Allou, N., Allyn, J., Jabot, J., & Lombardi, Y. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01477-5 · Cited by 5
“These results advocate against an early initiation of RRT in patients with leptospirosis and severe AKI outside the conventional framework and set of emergent criteria determined by large randomized studies [24–26].”
Lee, J. M., Baek, S. D., Kim, T. H., Jeon, H. R., Han, J., & Chang, J. W. (2021) · Shock · doi:10.1097/shk.0000000000001752 · Cited by 5
Cuidado de Alto Valor en Medicina Crítica
Ñamendys-Silva, S. A. (2019) · Medicina Crítica · doi:10.35366/87295 · Cited by 7
Quenot, J., Amrouche, I., Lefrant, J., Klouche, K., Jaber, S., du Cheyron, D., Duranteau, J., Maizel, J., Rondeau, É., Javouhey, É., et al. (2021) · Blood Purification · doi:10.1159/000518919 · Cited by 5
Self-citationOutcomes of Continuous Renal Replacement Therapy in a Community Health System
Schaffer, P., Chowdhury, R. B., Jordan, K. M., DeWitt, J., Elliott, J. O., & Schroeder, K. (2021) · Journal of Intensive Care Medicine · doi:10.1177/08850666211052871 · Cited by 5
Terapias de reemplazo renal agudo en pacientes críticos
Verónica Fuentes, A. (2024) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2023.12.001 · Cited by 5
Xie, Y., Chen, J., Xu, J., Shen, B., Liao, J., Teng, J., Wang, Q., & Ding, X. (2021) · Blood Purification · doi:10.1159/000515826 · Cited by 5
For safe and adequate blood purification therapy in severe COVID-19 ‒ what we have learned so far
Katagiri, D. (2022) · Global Health & Medicine · doi:10.35772/ghm.2022.01004 · Cited by 5
Guo, S., Chen, Y., Huo, Y., Zhao, C., Zhang, K., Zhang, X., Liu, M., & Hu, Z. (2023) · Translational Andrology and Urology · doi:10.21037/tau-23-146 · Cited by 6
“Takotsubo cardiomyopathy 12 [8] 5 [6] 7 [9] 0.”
Todur, P., Nileshwar, A., Chaudhuri, S., & Srinivas, T. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24553 · Cited by 5
“15,19,20 These “non-traditional” complications include inflammatory lung injury, cardiac dysfunction, and immune paralysis.”
BackgroundCao, Y., & Deng, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-62136-6 · Cited by 5
Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis
Barbar, S. D., Dargent, A., & Quenot, J. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1815142 · Cited by 5
Self-citationThe artificial kidney induces AKI? Not if we apply “kidney-protective” renal replacement therapy
Legrand, M. M., Prowle, J. R., & Forni, L. G. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05864-y · Cited by 5
Belcher, J. M. (2022) · Kidney360 · doi:10.34067/kid.0002162022 · Cited by 5
Kidney Replacement Therapy in the Intensive Care Unit
Wu, H. H. L., & Wang, A. Y.-M. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.2022.21.1.6 · Cited by 5
Guidelines for hospital nephrology assistance from the Brazilian Society of Nephrology (BSN)
Younes-Ibrahim, M., Rocha, E., Reis, T. D. A., Colares, V. S., de Lima, E. Q., Andrade, L., Rosa, E. C., Cardoso, H. S., Thomé, F. S., Ponce, D., et al. (2025) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2024-0239en · Cited by 4
Consensus document on the diagnosis and treatment of acute kidney injury
Ramos-Terrades, N., Benítez, P. R., Gallardo, J. M. U., Valdenebro, M., Salgueira, M., Andújar, A. M., Martins, J., Ramos-Galí, A., Moreno, J. A., Cuerda, C., et al. (2026) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2026.501360 · Cited by 5
“122”
Li, Y., Zhang, Y., Li, R., Zhang, M., & Gao, X. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13914 · Cited by 5
“[19] (2018) within 12 h after the onset of failure stage of RIFLE Severe hyperkalemia (>6 5 mmol/L); severe pulmonary edema refractory to diuretics; severe metabolic acidosis (pH <7 15); no renal function recovery after 48 h 7.”
BackgroundInfluentialA Systematic Bibliometric Analysis of High-Impact Articles in Critical Care Nephrology
Platnich, J. M., Kung, J. Y. C., Romanovsky, A. S., Ostermann, M., Wald, R., Pannu, N., & Bagshaw, S. M. (2023) · Blood Purification · doi:10.1159/000535558 · Cited by 5
“Several noteworthy trials have provided guidance on the optional application of acute RRT in critically ill patients with AKI, including timing of initiation [17, 18, 23, 26], dose [12, 14, 106], modality [21], and anticoagulation [29] that will likely serve as basis for an updated CPG.”
BackgroundNavigating the Labyrinth: Intensive Care Challenges for Patients with Acute-on-Chronic Liver Failure
Saner, F. H., Raptis, D. A., Alghamdi, S. A., Malagó, M., Broering, D., & Bezinover, D. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020506 · Cited by 7
“Additionally, it was demonstrated that there were risks associated with early RRT, including RRT dependency, an increased likelihood of bacteremia and catheter-related complications, bleeding problems, and higher resource consumption [52–54].”
BackgroundLee, J., Song, J., Kim, S. G., Yun, D., Kang, M. W., Kim, D. K., Oh, K., Joo, K. W., Kim, Y. S., Han, S. S., et al. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.116 · Cited by 6
Salmito, F. T. S., Mota, S. M. B., Holanda, F. M. T., Santos, L. L., de Andrade, L. S., Meneses, G. C., Lopes, N. C., de Araújo, L. M., Martins, A. M. C., & Libório, A. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-54926-9 · Cited by 5
“One major point of such trials is that a watch-and-wait strategy can prevent KRT in approximately 40–50% of included patients 6,9,10 .”
BackgroundNierenersatzverfahren bei akuter Nierenschädigung
Küllmar, M., & Zarbock, A. (2019) · Der Anaesthesist · doi:10.1007/s00101-019-0587-x · Cited by 4
The Role of Renal Pathology in the Prognosis and Recovery of Community-Acquired Acute Kidney Injury
Xu, J., Ruan, M., Wu, J., Huang, L., Xue, C., Chen, S., Mei, C., & Mao, Z. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000514287 · Cited by 4
9th International Congress “Sepsis and Multiorgan Dysfunction”
(2019) · Infection · doi:10.1007/s15010-019-01341-2 · Cited by 5
Outcomes of renal replacement therapy in the critically ill with COVID-19
Burke, E., Haber, E. N., Pike, C. W., & Sonti, R. (2021) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2021.02.006 · Cited by 5
Park, C. H., Koh, H. B., Lee, J. H., Jung, H.-Y., Ha, J., Kim, D. K., Park, J. T., Han, S. H., Kang, S., & Yoo, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-64224-z · Cited by 6
Shao, Y., Li, X., Zhou, W., Qian, S., Wang, L., & Fang, X. (2024) · Shock · doi:10.1097/shk.0000000000002431 · Cited by 6
“Septic shock is one of the most common causes of AKI in critically ill patients, with a mortality rate of approximately 50% (10,11).”
Yagnik, K. J., Mohan, G., Ketkar, A., Nivera, N., WEINER, S. M., Patton, C. D., & Du, D. T. (2024) · Cureus · doi:10.7759/cureus.74356 · Cited by 4
Managing Infectious Disease in the Critically Ill Elderly Patient
Mukherjee, K., Burruss, S. K., Brooks, S. E., & May, A. K. (2019) · Current Geriatrics Reports · doi:10.1007/s13670-019-00291-9 · Cited by 4
Barbar, S. D., Dargent, A., & Quenot, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.78 · Cited by 5
“for their interest in our study IDEAL-ICU (1) and appreciate their pertinent comments (2,3).”
Self-citationKindgen‐Milles, D., Heering, P., Meersch, M., Schmitz, M., Oppert, M., John, S., Jörres, A., Zarbock, A., & Willam, C. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00734-8 · Cited by 4
Dargent, A., Bourredjem, A., Argaud, L., Lévy, B., Fournel, I., Cransac, A., Badie, J. C., Quintin, L., & Quenot, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.968274 · Cited by 4
“In the absence of these criteria and in light of recent data (34), we suggest postponing the initiation of RRT in patients with persistent acute kidney injury until hemodynamic stabilization is achieved.”
BackgroundSelf-citationLi, Z., Zhang, H., Xie, K., Zhang, Y., Zhang, Z., Zheng, W., Yang, T., Zhang, L., & Yu, Y. (2023) · Shock · doi:10.1097/shk.0000000000002090 · Cited by 4
“Similarly, in septic shock patients with severe AKI in the IDEAL-ICU trial, there was no significant difference in overall mortality at 90 days between the early and delayed RRT strategies (16).”
BackgroundSepsis Associated Acute Kidney Injury
Ahmed, S. M. G., Mahmoud, E., Abusannuga, M. M., Attique, Z., & Al-Ali, J. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008884 · Cited by 5
Renal replacement therapy: Time to give up on early initiation? Yes
Barbar, S. D., Gaudry, S., Dreyfuss, D., & Quenot, J. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.11.008 · Cited by 4
Self-citationDelaying Renal Replacement Therapy Could Be Harmful in Patients with Acute Brain Injury
Chousterman, B. G., Jamme, M., Tabibzadeh, N., Gaugain, S., Damoisel, C., & Barthélémy, R. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0527le · Cited by 4
Renal Replacement Therapy in Pregnancy-related Acute Kidney Injury: Getting the Timing Right
Lobo, V. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23540 · Cited by 4
No “optimal timing” of renal-replacement therapy in critically ill patients with acute kidney injury
Zhang, Z. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.62 · Cited by 4
Dialysis decision in critically ill patients in intensive care unit
Rhee, H. (2025) · Acute and Critical Care · doi:10.4266/acc.004896 · Cited by 3
Mortality time frame variability in septic shock clinical trials: A systematic review
Laserna, A., Cuenca, J. A., Martin, P., Fowler, C., Correa, J. E. B., Manjappachar, N. K., Fowler, C. S., Lopez-Olivo, M. A., Borges, M., Sprung, C. L., et al. (2025) · Medicina Intensiva · doi:10.1016/j.medine.2025.502172 · Cited by 7
Alrashdi, A. S., Alshammari, J. N., Abdullah, S. K., Alqannas, S. I., Faqeehi, H., Albatati, S., Rahim, K. A., Sandokji, I. A., Alanazi, A., & Alzabali, S. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06794-2 · Cited by 3
“At ICU admission, PRISM III scores were significantly higher in the deceased group (median = 10 [8,–16]) than in the survived group (median = 7 [3,–13]; p < 0.01).”
InfluentialPérez-Garzón, M., Castillo-Castillo, A., Ferro-Peñuela, M., Poveda-Henao, C., Díaz, M. A. M., & Robayo-Amórtegui, H. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04395-7 · Cited by 3
Landzberg, E. I., Ogdie, A., Yarnell, C. J., Harhay, M. O., & Yehya, N. (2025) · Critical Care · doi:10.1186/s13054-025-05663-6 · Cited by 3
Moreira, R. A., Borges, S., Borges, S. L. D. S., & Magro, M. C. D. S. (2025) · Biomedicines · doi:10.3390/biomedicines13112575 · Cited by 3
“Other large multicenter trials, such as IDEAL-ICU [8], AKIKI [11], AKIKI II [12], and STAART-AKI [13], found no significant difference in mortality between early and delayed strategies.”
Ice, S. D., Pellegrino, B. S., Diab, A., Parravani, A. J., Poling, M. A., Sakhuja, A., KASHANI, K. B., & Shawwa, K. (2026) · Journal of Critical Care · doi:10.1016/j.jcrc.2026.155505 · Cited by 3
Experts’ recommendations for the management of adult patients with cardiogenic shock
Aïssaoui, N., Delmas, C., Merdji, H., Schurtz, G., Baudry, G., Beurton, A., Boissier, F., Bonello, L., Cholley, B., Combaret, N., et al. (2026) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2026.02.001 · Cited by 4
Experts’ recommendations for the management of adult patients with cardiogenic shock
Aïssaoui, N., Delmas, C., Merdji, H., Schurtz, G., Baudry, G., Beurton, A., Boissier, F., Bonello, L., Cholley, B., Combaret, N., et al. (2026) · Annals of Intensive Care · doi:10.1016/j.aicoj.2026.100038 · Cited by 3
Fosset, M., Pensier, J., Jabaudon, M., Bitker, L., JONG, A. D., Chanques, G., Huguet, H., Molinari, N., Jaber, S., & Jung, B. (2026) · Critical Care · doi:10.1186/s13054-026-06206-3 · Cited by 3
“Furthermore, early initiation of RRT has not demonstrated a mortality benefit in randomized trials of critically ill patients with AKI, and may expose patients to unnecessary procedures in the absence of urgent indications [26, 27].”
InfluentialSelf-citationEarly goal-directed renal replacement therapy in severe pneumonia associated acute kidney injury
Yusufu, A., Xie, Y., Shi, Y., Jiang, W., Hu, J., Lv, W., Ding, X., Teng, J., Shen, B., Bi, J., et al. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2392844 · Cited by 3
“Patients in Early RRt group showed significantly lower SCr [125(78,204) μmol/l vs. 193(120,297) μmol/l, p = 0.002] and Bun [16(10,27) mmol/l vs. 26(10,32) mmol/l, p = 0.012] levels, and higher urinary output [430(55,1275) ml vs. 150(30,400) ml, p = 0.013] at discharge than those in late RRt group…”
BackgroundResultInfluentialSerre, J., Mulier, G., Boud’hors, C., Lemerle, M., Abdel-Nabey, M., Orvain, C., Chaba, A., Biard, L., Demiselle, J., & Zafrani, L. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01439-x · Cited by 3
“Several clinical trials have investigated the optimal timing for initiating KRT in AKI [11–13].”
Lumlertgul, N., Wannakittirat, A., Kung, J. Y. C., Srisawat, N., Collister, D., See, E. J., Pannu, N., Mehta, R. L., Soranno, D. E., Ostermann, M., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04202-y · Cited by 3
Perioperative acute kidney injury: current prevention, detection, and management strategies
Mangano, N., Nguyen, N. Q., Davis, M., Key, B., Feit, A., & Bergese, S. D. (2025) · Journal of Anesthesia · doi:10.1007/s00540-025-03596-6 · Cited by 3
COVID-19 und akute Nierenschädigung im Intensivbereich
Hardenberg, J.-H., Stockmann, H., Eckardt, K., & Schmidt-Ott, K. M. (2020) · Der Nephrologe · doi:10.1007/s11560-020-00471-1 · Cited by 4
“Damit liegen nun 3 randomisierte multizentrische Studien (AKIKI, IDEAL ICU, STARRT AKI) vor, die übereinstimmend keinen Benefit von frühem Dialysebeginn zeigen konnten [5, 6, 15].”
BackgroundParamitha, M. P., Suyanto, J. C., & Puspitasari, S. (2021) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2021.06.003 · Cited by 3
“In contrast, another randomized controlled trial involving 477 patients studied the 90-days mortality between the initiation of CRRT within 12 h of acute kidney injury (early strategy) and a delay of 48 h (delayed strategy) [42].”
Organizational and financial aspects of a continuous renal replacement therapy program
Connor, M. J., Jr., Lischer, E., & Cerdá, J. (2021) · Seminars in Dialysis · doi:10.1111/sdi.13013 · Cited by 3
Metadata
- Authors
- Barbar, S. D., Clere-Jehl, R., Bourredjem, A., Hernu, R., Montini, F., Bruyère, R., Lebert, C., Bohé, J., Badie, J., Eraldi, J.-P., Rigaud, J.-P., Levy, B., Siami, S., Louis, G., Bouadma, L., Constantin, J.-M., Mercier, E., Klouche, K., du Cheyron, D., Piton, G., Annane, D., Jaber, S., van der Linden, T., Blasco, G., Mira, J.-P., Schwebel, C., Chimot, L., Guiot, P., Nay, M.-A., Meziani, F., Helms, J., Roger, C., Louart, B., Trusson, R., Dargent, A., Binquet, C., & Quenot, J.-P.
- Affiliations
- Inserm (FR)
- From Réanimation Médicale, Centre Hospitalier Universitaire (CHU) de Nîmes (S.D.B., B. Louart, R.T.), and Saint Eloi, CHU de Montpellier, Université de Montpellier, and INSERM Unité 1046 (S.J.), Service de Réanimation Médicale, CHU Lapeyronie (K.K.), Montpellier, Université de Strasbourg, Faculté de Médecine, Hôpitaux Universitaires de Strasbourg, Service de Réanimation, Nouvel Hôpital Civil, Strasbourg (R.C.-J., F. Meziani, J.H.), Service de Médecine Intensive Réanimation, Hôpital Universitaire...
- ORCID
- Barbar, Saber D.
- Clere-Jehl, Raphaël
- Bourredjem, Abderrahmane
- Siami, Shidasp
- Louis, Guillaume
- Bouadma, Lila
- Constantin, Jean-Michel
- Klouche, Kada
- Piton, Gaël
- Annane, Djillali
- Jaber, Samir
- Mira, Jean-Paul
- Schwebel, Carole
- Nay, Mai-Anh
- Meziani, Ferhat
- Helms, Julie
- Roger, Claire
- Louart, Benjamin
- Dargent, Auguste
- Binquet, Christine
- Quenot, Jean-Pierre
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-10-11
- Volume
- 379
- Issue
- 15
- Pages
- 1431-1442
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2896124705
- Cited by
- 777
- References
- 23
- Citations by year
- 2026: 102 · 2025: 111 · 2024: 102 · 2023: 73 · 2022: 99 · 2021: 96 · 2020: 105 · 2019: 77 · 2018: 11
- FWCI
- 58.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- French Ministry of Health (PHRC 2011 A00519-34)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- acute kidney injury, septic shock, sepsis, renal replacement therapy, time to treatment, RIFLE criteria, mortality, emergency dialysis, anuria
- MeSH terms
- Aged, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Shock, Septic, Survival Analysis, Treatment Failure, Renal Replacement Therapy, Acute Kidney Injury, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.